Cargando…
Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19
Identifying patients at increased risk for severe COVID-19 is of high priority during the pandemic as it could affect clinical management and shape public health guidelines. In this study we assessed whether a second PCR test conducted 2–7 days after a SARS-CoV-2 positive test could identify patient...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516879/ https://www.ncbi.nlm.nih.gov/pubmed/34650138 http://dx.doi.org/10.1038/s41598-021-99671-5 |
_version_ | 1784583889785716736 |
---|---|
author | Mizrahi, Barak Bivas-Benita, Maytal Kalkstein, Nir Akiva, Pinchas Yanover, Chen Yehezkelli, Yoav Kessler, Yoav Alon, Sharon Hermoni Rubin, Eitan Chodick, Gabriel |
author_facet | Mizrahi, Barak Bivas-Benita, Maytal Kalkstein, Nir Akiva, Pinchas Yanover, Chen Yehezkelli, Yoav Kessler, Yoav Alon, Sharon Hermoni Rubin, Eitan Chodick, Gabriel |
author_sort | Mizrahi, Barak |
collection | PubMed |
description | Identifying patients at increased risk for severe COVID-19 is of high priority during the pandemic as it could affect clinical management and shape public health guidelines. In this study we assessed whether a second PCR test conducted 2–7 days after a SARS-CoV-2 positive test could identify patients at risk for severe illness. Analysis of a nationwide electronic health records data of 1683 SARS-CoV-2 positive individuals indicated that a second negative PCR test result was associated with lower risk for severe illness compared to a positive result. This association was seen across different age groups and clinical settings. More importantly, it was not limited to recovering patients but also observed in patients who still had evidence of COVID-19 as determined by a subsequent positive PCR test. Our study suggests that an early second PCR test may be used as a supportive risk-assessment tool to improve disease management and patient care. |
format | Online Article Text |
id | pubmed-8516879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-85168792021-10-15 Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19 Mizrahi, Barak Bivas-Benita, Maytal Kalkstein, Nir Akiva, Pinchas Yanover, Chen Yehezkelli, Yoav Kessler, Yoav Alon, Sharon Hermoni Rubin, Eitan Chodick, Gabriel Sci Rep Article Identifying patients at increased risk for severe COVID-19 is of high priority during the pandemic as it could affect clinical management and shape public health guidelines. In this study we assessed whether a second PCR test conducted 2–7 days after a SARS-CoV-2 positive test could identify patients at risk for severe illness. Analysis of a nationwide electronic health records data of 1683 SARS-CoV-2 positive individuals indicated that a second negative PCR test result was associated with lower risk for severe illness compared to a positive result. This association was seen across different age groups and clinical settings. More importantly, it was not limited to recovering patients but also observed in patients who still had evidence of COVID-19 as determined by a subsequent positive PCR test. Our study suggests that an early second PCR test may be used as a supportive risk-assessment tool to improve disease management and patient care. Nature Publishing Group UK 2021-10-14 /pmc/articles/PMC8516879/ /pubmed/34650138 http://dx.doi.org/10.1038/s41598-021-99671-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Mizrahi, Barak Bivas-Benita, Maytal Kalkstein, Nir Akiva, Pinchas Yanover, Chen Yehezkelli, Yoav Kessler, Yoav Alon, Sharon Hermoni Rubin, Eitan Chodick, Gabriel Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19 |
title | Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19 |
title_full | Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19 |
title_fullStr | Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19 |
title_full_unstemmed | Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19 |
title_short | Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19 |
title_sort | results of an early second pcr test performed on sars-cov-2 positive patients may support risk assessment for severe covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516879/ https://www.ncbi.nlm.nih.gov/pubmed/34650138 http://dx.doi.org/10.1038/s41598-021-99671-5 |
work_keys_str_mv | AT mizrahibarak resultsofanearlysecondpcrtestperformedonsarscov2positivepatientsmaysupportriskassessmentforseverecovid19 AT bivasbenitamaytal resultsofanearlysecondpcrtestperformedonsarscov2positivepatientsmaysupportriskassessmentforseverecovid19 AT kalksteinnir resultsofanearlysecondpcrtestperformedonsarscov2positivepatientsmaysupportriskassessmentforseverecovid19 AT akivapinchas resultsofanearlysecondpcrtestperformedonsarscov2positivepatientsmaysupportriskassessmentforseverecovid19 AT yanoverchen resultsofanearlysecondpcrtestperformedonsarscov2positivepatientsmaysupportriskassessmentforseverecovid19 AT yehezkelliyoav resultsofanearlysecondpcrtestperformedonsarscov2positivepatientsmaysupportriskassessmentforseverecovid19 AT kessleryoav resultsofanearlysecondpcrtestperformedonsarscov2positivepatientsmaysupportriskassessmentforseverecovid19 AT alonsharonhermoni resultsofanearlysecondpcrtestperformedonsarscov2positivepatientsmaysupportriskassessmentforseverecovid19 AT rubineitan resultsofanearlysecondpcrtestperformedonsarscov2positivepatientsmaysupportriskassessmentforseverecovid19 AT chodickgabriel resultsofanearlysecondpcrtestperformedonsarscov2positivepatientsmaysupportriskassessmentforseverecovid19 |